AKBA
Akebia Therapeutics Inc
Price:  
1.10 
USD
Volume:  
1,606,864.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AKBA WACC - Weighted Average Cost of Capital

The WACC of Akebia Therapeutics Inc (AKBA) is 6.8%.

The Cost of Equity of Akebia Therapeutics Inc (AKBA) is 7.05%.
The Cost of Debt of Akebia Therapeutics Inc (AKBA) is 6.75%.

Range Selected
Cost of equity 5.90% - 8.20% 7.05%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 6.50% - 7.00% 6.75%
WACC 5.8% - 7.8% 6.8%
WACC

AKBA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.44 0.59
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.90% 8.20%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.15 0.15
Cost of debt 6.50% 7.00%
After-tax WACC 5.8% 7.8%
Selected WACC 6.8%